NDC 16590-620

NDC 16590-620

NDC 16590-620 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 16590-620
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 16590-620-60 [16590062060]

PERCOCET TABLET
Marketing CategoryANDA
Application NumberANDA040341
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1999-07-30
Inactivation Date2019-10-21

NDC 16590-620-73 [16590062073]

PERCOCET TABLET
Marketing CategoryANDA
Application NumberANDA040341
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1999-07-30
Inactivation Date2019-10-21

NDC 16590-620-56 [16590062056]

PERCOCET TABLET
Marketing CategoryANDA
Application NumberANDA040341
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1999-07-30
Inactivation Date2019-10-21

NDC 16590-620-72 [16590062072]

PERCOCET TABLET
Marketing CategoryANDA
Application NumberANDA040341
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1999-07-30
Inactivation Date2019-10-21

NDC 16590-620-62 [16590062062]

PERCOCET TABLET
Marketing CategoryANDA
Application NumberANDA040341
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1999-07-30
Inactivation Date2019-10-21

NDC 16590-620-82 [16590062082]

PERCOCET TABLET
Marketing CategoryANDA
Application NumberANDA040341
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1999-07-30
Inactivation Date2019-10-21

NDC 16590-620-30 [16590062030]

PERCOCET TABLET
Marketing CategoryANDA
Application NumberANDA040341
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1999-07-30
Inactivation Date2019-10-21

NDC 16590-620-90 [16590062090]

PERCOCET TABLET
Marketing CategoryANDA
Application NumberANDA040341
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1999-07-30
Inactivation Date2019-10-21

NDC 16590-620-83 [16590062083]

PERCOCET TABLET
Marketing CategoryANDA
Application NumberANDA040341
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1999-07-30
Inactivation Date2019-10-21

Drug Details


© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.